Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Neuropharmacology. 2016 Sep 15;113(Pt A):60–70. doi: 10.1016/j.neuropharm.2016.09.016

Figure 7. Structures of (a) ivermectin and (b) MOX.

Figure 7

Major structural differences are noted. C13: ivermectin contains a disaccharide while MOX is protonated; C23: MOX has a methoxime; C25: ivermectin is a mixture of C25-ethyl (~10%) or C25-methyl (~90%) groups while MOX has a dimethyl-butyl substituent.